— Know what they know.
Not Investment Advice

HOWL NASDAQ

Werewolf Therapeutics, Inc.
1W: -3.3% 1M: -7.0% 3M: +190.0% YTD: +43.9% 1Y: -52.4% 3Y: -58.2% 5Y: -94.8%
$0.93
+0.05 (+5.29%)
 
Weekly Expected Move ±6.5%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 50 · $45.1M mcap · 42M float · 1.49% daily turnover · Short 34% of daily vol

📊 Key Metrics

TTM
$21M
Revenue
+0.0% YoY
$-35M
Net Income
+52.7% YoY
$-30M
Free Cash Flow
+50.5% YoY
88.3%
Gross Margin
40.7%
Op. Margin
17.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-119.9%
ROA-59.3%
ROIC354.7%

Valuation

P/E-1.3
P/B2.8
EV/EBITDA0.2

Leverage

Debt/Equity0.00
Current Ratio2.91
Interest Cov.-6.8x

Quality Scores

Piotroski F4/9
Altman Z-28.78
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms